(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(0.07%) $83.42
(-0.33%) $1.806
(-0.04%) $2 341.10
(0.43%) $27.48
(0.27%) $925.30
(-0.02%) $0.934
(-0.17%) $10.89
(-0.02%) $0.803
(0.00%) $93.19
Quarter results today
(bmo 2024-04-24)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Today's Volume | 28 142.00 |
Average Volume | 67 785.00 |
Market Cap | 10.11B |
EPS | SEK0 ( 2024-04-23 ) |
Next earnings date | ( SEK0 ) 2024-07-12 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | 104.22 |
ATR14 | SEK0.670 (0.21%) |
Volume Correlation
Xvivo Perfusion AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Xvivo Perfusion AB (publ) Correlation - Currency/Commodity
Xvivo Perfusion AB (publ) Financials
Annual | 2023 |
Revenue: | SEK597.54M |
Gross Profit: | SEK416.91M (69.77 %) |
EPS: | SEK3.07 |
Q4 | 2023 |
Revenue: | SEK155.74M |
Gross Profit: | SEK87.98M (56.49 %) |
EPS: | SEK2.17 |
Q3 | 2023 |
Revenue: | SEK146.61M |
Gross Profit: | SEK107.60M (73.39 %) |
EPS: | SEK0.0758 |
Q2 | 2023 |
Revenue: | SEK154.57M |
Gross Profit: | SEK115.46M (74.70 %) |
EPS: | SEK0.230 |
Financial Reports:
No articles found.
Xvivo Perfusion AB (publ)
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators